Replies to post #118164 on Biotech Values

[DewDiligence]

Ok—I’m convinced. I will repost the script table with your explanation for the March bump in market share.

[exwannabe]

SNY won't admit it but they had a shortage for all syringe doses especially the HD syringes because they were anticipating a TEVA entry that never came into fruition..

So all along TEVA has been secretly helping MNTA out by the BS "we will be approved next month" claims. :-)

Is there any "stickyness" in this effect? Once the shortage is over will there be less of a gap between the product price/demand curves than there would have been w/o the shortage?

Might Sandoz need to raise prices a bit?